Wird geladen...
(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
BACKGROUND: (123)I‐Metaiodobenzylguanidine ((123)I‐MIBG) myocardial scintigraphy is a useful technique to differentiate Parkinson's disease (PD) from atypical parkinsonisms, since it is generally abnormal in PD and normal in the latter. Reduction of myocardial MIBG uptake is a supportive featur...
Gespeichert in:
| Veröffentlicht in: | Mov Disord Clin Pract |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Inc.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8287155/ https://ncbi.nlm.nih.gov/pubmed/34295947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.13227 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|